Bio-Works Technologies AB (publ) (NGM:BIOWKS)
2.490
-0.150 (-5.68%)
At close: Nov 5, 2025
Bio-Works Technologies AB Revenue
Bio-Works Technologies AB had revenue of 16.68M SEK in the quarter ending September 30, 2025, with 70.08% growth. This brings the company's revenue in the last twelve months to 40.83M, down -6.78% year-over-year. In the year 2024, Bio-Works Technologies AB had annual revenue of 30.49M, down -30.55%.
Revenue (ttm)
40.83M
Revenue Growth
-6.78%
P/S Ratio
5.41
Revenue / Employee
1.41M
Employees
30
Market Cap
221.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.49M | -13.41M | -30.55% |
| Dec 31, 2023 | 43.90M | 2.58M | 6.23% |
| Dec 31, 2022 | 41.32M | -15.04M | -26.68% |
| Dec 31, 2021 | 56.36M | 49.13M | 679.08% |
| Dec 31, 2020 | 7.23M | 1.66M | 29.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |